GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 56.88 billion. The enterprise value is 70.32 billion.
Market Cap | 56.88B |
Enterprise Value | 70.32B |
Important Dates
The last earnings date was Monday, April 28, 2025.
Earnings Date | Apr 28, 2025 |
Ex-Dividend Date | May 15, 2025 |
Share Statistics
GSK plc has 4.06 billion shares outstanding. The number of shares has increased by 0.73% in one year.
Current Share Class | 4.06B |
Shares Outstanding | 4.06B |
Shares Change (YoY) | +0.73% |
Shares Change (QoQ) | -0.19% |
Owned by Insiders (%) | 0.11% |
Owned by Institutions (%) | 88.33% |
Float | 3.93B |
Valuation Ratios
The trailing PE ratio is 18.39 and the forward PE ratio is 8.19. GSK plc's PEG ratio is 1.22.
PE Ratio | 18.39 |
Forward PE | 8.19 |
PS Ratio | 1.80 |
PB Ratio | 4.17 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 1.22 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.93, with an EV/FCF ratio of 13.07.
EV / Earnings | 22.30 |
EV / Sales | 2.23 |
EV / EBITDA | 7.93 |
EV / EBIT | 11.25 |
EV / FCF | 13.07 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.35.
Current Ratio | 0.87 |
Quick Ratio | 0.58 |
Debt / Equity | 1.35 |
Debt / EBITDA | 2.08 |
Debt / FCF | 3.42 |
Interest Coverage | 10.32 |
Financial Efficiency
Return on equity (ROE) is 27.10% and return on invested capital (ROIC) is 12.39%.
Return on Equity (ROE) | 27.10% |
Return on Assets (ROA) | 6.55% |
Return on Invested Capital (ROIC) | 12.39% |
Return on Capital Employed (ROCE) | 15.68% |
Revenue Per Employee | 459,412 |
Profits Per Employee | 45,943 |
Employee Count | 68,629 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.51 |
Taxes
In the past 12 months, GSK plc has paid 754.00 million in taxes.
Income Tax | 754.00M |
Effective Tax Rate | 14.39% |
Stock Price Statistics
The stock price has decreased by -24.26% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
Beta (5Y) | 0.27 |
52-Week Price Change | -24.26% |
50-Day Moving Average | 1,434.94 |
200-Day Moving Average | 1,448.43 |
Relative Strength Index (RSI) | 43.53 |
Average Volume (20 Days) | 10,116,611 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 31.53 billion and earned 3.15 billion in profits. Earnings per share was 0.76.
Revenue | 31.53B |
Gross Profit | 22.68B |
Operating Income | 6.25B |
Pretax Income | 4.23B |
Net Income | 3.15B |
EBITDA | 8.65B |
EBIT | 6.25B |
Earnings Per Share (EPS) | 0.76 |
Balance Sheet
The company has 4.49 billion in cash and 18.43 billion in debt, giving a net cash position of -13.95 billion or -3.43 per share.
Cash & Cash Equivalents | 4.49B |
Total Debt | 18.43B |
Net Cash | -13.95B |
Net Cash Per Share | -3.43 |
Equity (Book Value) | 13.65B |
Book Value Per Share | 3.47 |
Working Capital | -2.75B |
Cash Flow
In the last 12 months, operating cash flow was 6.74 billion and capital expenditures -1.36 billion, giving a free cash flow of 5.38 billion.
Operating Cash Flow | 6.74B |
Capital Expenditures | -1.36B |
Free Cash Flow | 5.38B |
FCF Per Share | 1.32 |
Margins
Gross margin is 71.92%, with operating and profit margins of 19.83% and 10.00%.
Gross Margin | 71.92% |
Operating Margin | 19.83% |
Pretax Margin | 13.42% |
Profit Margin | 10.00% |
EBITDA Margin | 27.45% |
EBIT Margin | 19.83% |
FCF Margin | 17.07% |
Dividends & Yields
This stock pays an annual dividend of 0.61, which amounts to a dividend yield of 4.43%.
Dividend Per Share | 0.61 |
Dividend Yield | 4.43% |
Dividend Growth (YoY) | 5.08% |
Years of Dividend Growth | 1 |
Payout Ratio | 78.91% |
Buyback Yield | -0.73% |
Shareholder Yield | 3.70% |
Earnings Yield | 5.54% |
FCF Yield | 9.46% |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
Last Split Date | Jul 19, 2022 |
Split Type | Reverse |
Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.78 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.78 |
Piotroski F-Score | 7 |